OncoLog, Volume 34, Number 03, July-September 1989

Authors

Stephen L. Huber MS, The University of Texas MD Anderson Cancer Center
Nicky Dozier PharmD, The University of Texas MD Anderson Cancer Center
Naguib A. Samaan MD, PhD, The University of Texas MD Anderson Cancer Center

Files

Contents

• Understanding Dose Intensity is Essential for Optimizing Chemotherapeutic Regimens
• Dysplastic Nevus Syndrome Identifies Patients at High Risk for Melanoma
• Multiple Endocrine Neoplasia Syndromes

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Publication Date

1989

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Huber, Stephen L.; Dozier, Nicky; Samaan, Naguib A., 1925-; Greene, Mark H., 1944- Duvic, Madeleine; Kopf, Alfred W.; Antineoplastic Agents -- administration & dosage; Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Multiple Endocrine Neoplasia; Calcitonin; Melanoma; Dysplastic Nevus Syndrome; Early Detection of Cancer; Diagnostic Screening Programs.

Disciplines

History of Science, Technology, and Medicine | Oncology

Recommended Citation

Huber, Stephen L. MS; Dozier, Nicky PharmD; and Samaan, Naguib A. MD, PhD, "OncoLog, Volume 34, Number 03, July-September 1989" (1989). OncoLog MD Anderson's Report to Physicians (All issues). 25.
https://openworks.mdanderson.org/oncolog/25

Conditions Governing Access

Open